BCI
IBBQ icon

Brinker Capital Investments’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Brinker Capital Investments’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$646K Buy
19,790
+6,037
+44% +$179K ﹤0.01% 1372
2026
Q1 		$399K Sell
13,753
-48
-0.3% -$1.4K ﹤0.01% 1545
2025
Q4 		$392K Buy
+13,801
New +$376K ﹤0.01% 1692

Other funds holding IBBQ

Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Brinker Capital Investments's IBBQ Position: Q2 2026 in Review

Brinker Capital Investments increased its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 44% in Q2 2026, buying an estimated $179K and bringing the position to 19,790 shares worth $646K. The position accounts for ﹤0.01% of the portfolio, ranked #1372.

Brinker Capital Investments first reported a position in IBBQ in Q4 2025 and has held it in 3 quarters since. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

  • Brinker Capital Investments held 19,790 shares of Invesco NASDAQ Biotechnology ETF worth $646K as of Q2 2026.
  • Brinker Capital Investments bought 6,037 Invesco NASDAQ Biotechnology ETF shares in Q2 2026, an estimated $179K.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1372 holding.
  • Brinker Capital Investments first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • 35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.